Article

Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased…

medRxiv · 2024 · Laight, B. J.; Harper, D.; Dmytryk, N.; Zhang, C. S.; Garven, A.; Shi, C.; Nauman, R.; Kment, J.; Alotaibi, F.; Gao, Y.; Vlasschaert, C.; LeBrun, D.; Tyryshkin, K.; Berman, D. M.; Simpson, A. L.; Graham, C.; Craig, A.; Basta, S.; Koti, M.; Greer, P. A.

Key facts

Title Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased proinflammatory cytokine production and presentation
First author Laight, B. J.; Harper, D.; Dmytryk, N.; Zhang, C. S.; Garven, A.; Shi, C.; Nauman, R.; Kment, J.; Alotaibi, F.; Gao, Y.; Vlasschaert, C.; LeBrun, D.; Tyryshkin, K.; Berman, D. M.; Simpson, A. L.; Graham, C.; Craig, A.; Basta, S.; Koti, M.; Greer, P. A.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.02.27.581601
Devices mentioned BK110039, DEN000008, K010696, K022086, K073490, K103302
Product codes mentioned CFN, JCI, KIP, KIT, LCD, MVU, NDS, NJT, OOI, JIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature